Related Experiment Video
Updated: Sep 20, 2026
09:49
Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
The Cambridge Healthtech Institute's 9th Annual Conference on Blood Safety
1Head, Blood and Tissues Unit, Therapeutic Goods Administration, PO Box 100 Woden, ACT, Australia 2606. albert.farrugia@health.gov.au
Expert Opinion on Drug Safety
|August 9, 2003
Insights
This commentary reviews the 2003 Cambridge HealthTech Institute
Area of Science:
- Blood safety research and development.
- Health technology advancements.
- Biopharmaceutical industry insights.
Background:
- Summary of key discussions and presentations at the 2003 Cambridge HealthTech Institute Conference on Blood Safety.
- Personal commentary on the state of blood safety in early 2003.
Framework:
- The conference covered diverse areas critical to blood safety.
- Expert speakers provided high-caliber insights.
Implementation:
- Discussions likely encompassed transfusion medicine, diagnostics, and regulatory aspects.
- Focus on emerging technologies and best practices in blood product management.
Implications:
- Highlights the importance of continuous dialogue and innovation in blood safety.
- Provides a historical perspective on advancements in the field.
Abstract:
This article summarises, and provides a personal commentary on, the Cambridge HealthTech Institute's Conference on Blood Safety in February 2003. Most of the converging areas which contribute to this field were amply covered at the conference by speakers of a high calibre and international standing.
